Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to complete so might be grounds for compensation. Our lawyers are operating difficult to get those hurt by the drug the compensation they're entitled to.While bleeding is really a typical complication related with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, patients may possibly be at danger for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.If you or even a loved 1 suffered a severe bleeding event right after taking Xarelto, you may have legal recourse. For much more details, make contact with us nowadays to possess your case reviewed, totally free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral expenditures. Furthermore, they may be looking for punitive damages, which are normally awarded to punish the defendant and deter other companies from acting similarly.rjk-attorneys.net Why Are Lawsuits Becoming Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.Visit this page for a lot more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to perform so may be grounds for compensation. Our lawyers are working hard to have those hurt by the drug the compensation they're entitled to.Whilst bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is more harmful than standard blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, individuals could be at threat for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.Should you or possibly a loved one particular suffered a critical bleeding event right after taking Xarelto, you might have legal recourse. For a lot more details, speak to us today to possess your case reviewed, free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in situations of death, funeral expenses. In addition, they may be in search of punitive damages, that are typically awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. just click the up coming internet site plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a protected anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for a lot more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are operating hard to get these hurt by the drug the compensation they're entitled to.Whilst bleeding is actually a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more unsafe than classic blood thinners because no antidote exists to reverse its blood-thinning effects. try this website implies that, inside the event of an emergency, sufferers may possibly be at danger for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.In the event you or even a loved one suffered a significant bleeding occasion following taking Xarelto, you might have legal recourse. For far more information, contact us nowadays to have your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. In addition, they are seeking punitive damages, that are usually awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for much more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are working tough to have these hurt by the drug the compensation they are entitled to.While bleeding is actually a typical complication related with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, sufferers could be at threat for irreversible bleeding issues, such as life-threatening internal and gastrointestinal hemorrhaging.In the event you or perhaps a loved 1 suffered a severe bleeding occasion following taking Xarelto, you may have legal recourse. For far more data, contact us these days to possess your case reviewed, free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Additionally, they may be searching for punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, my company doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for far more details on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so might be grounds for compensation. Our lawyers are working tough to have these hurt by the drug the compensation they are entitled to.Even though bleeding is a typical complication related with anticoagulants, it has been alleged that Xarelto is a lot more dangerous than standard blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, individuals may possibly be at danger for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.Should you or perhaps a loved one suffered a significant bleeding occasion following taking Xarelto, you may have legal recourse. For much more data, get in touch with us nowadays to possess your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenditures. Furthermore, they are searching for punitive damages, that are normally awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer here. and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.